N. Yang

发表

Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients.

T. Stamey, J. McNeal, J. Kabalin, 1989, The Journal of urology.

Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the Prostate

T. Stamey, J. McNeal, F. Freiha, 1987 .

Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate.

T. Stamey, J. McNeal, F. Freiha, 1988, The New England journal of medicine.

IMMUNOLOGICAL AND CLINICAL SPECIFICITY OF THE IMMUNOCHEMICAL DETERMINATION OF PROSTATIC ACID PHOSPHATASE

L. Shaw, N. Yang, W. Croop, 1982, Annals of the New York Academy of Sciences.

Immunochemical evaluation of the organ specificity of prostatic acid phosphatase.

L. Shaw, N. Yang, J. Brooks, 1981, Clinical chemistry.

Prognostic importance of prostate-specific antigen for monitoring patients with stages B2 to D1 prostate cancer.

N. Yang, G. Murphy, T. M. Chu, 1985, Cancer research.

Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. IV. Anti-androgen treated patients.

T. Stamey, J. Kabalin, N. Yang, 1989, The Journal of urology.

Evaluation of prostate-specific antigen and prostatic acid phosphatase as prostate cancer markers.

L. Shaw, N. Yang, B. Seamonds, 1986, Urology.

Relative reliability of five serially measured markers for prognosis of progression in prostate cancer.

N. Yang, R. Priore, G. Murphy, 1986, Journal of the National Cancer Institute.